Objective:

To reaffirm the ethical duty of physicians in organ transplantation, focusing on donor-patient welfare.

Approach:

• Ethical Guidance: The ACP outlined updated guidance on donation after circulatory death, informed consent, and fairness in organ allocation.
• Independent Decision-Making: The decision to withdraw life-sustaining treatment must remain independent of donation decisions.
• Communication with Families: The ACP recommended communicating the possibility of survival after planned donation to families in advance.
• Ethical Concerns: The paper highlighted concerns with thoracoabdominal normothermic regional perfusion and its potential to blur compliance with the dead donor rule.
• Informed Consent: The ACP found that presumed consent systems yield marginal increases in available organs and advised donation discussions post-decision on life support.
• Addressing Inequities: The ACP identified systemic inequities in organ allocation, particularly affecting Black patients, and recommended transparency measures.
• Regulatory Metrics: The organization warned against regulatory metrics and financial incentives influencing patient care.

Key Findings:

• Up to half of planned donations after circulatory death did not proceed due to unexpected death timing.
• Presumed consent systems yield only 0% to 5% increases in available organs.
• Black patients are less likely than White patients to have donor hearts accepted despite similar medical profiles.
• 56 organ procurement organizations operate under performance targets that may create conflicting priorities.

Interpretation:

Limitations:

• The guidance reflects ethical consensus rather than quantitative analysis.
• Recommendations may vary in application across jurisdictions.

Conclusion:

The ACP calls on physicians to uphold transparency, fairness, and patient welfare in the evolving field of transplantation.

Sources:

• Annals of Internal Medicine